EHC and EUPATI Partner to Advance Patient Education and Engagement in Therapeutic Innovation
The European Haemophilia Consortium (EHC) recently shared an announcement post on X:
”EHC has partnered with The European Patients’ Academy on Therapeutic Innovation to enhance education and research for European Patients. Together, we’ll strengthen the voice of the rare Bleeding Disorders community & improve outcomes across Europe.”
To read more, follow the link.
European Haemophilia Consortium has announced a new partnership with the European Patients’ Academy of Therapeutic Innovation (EUPATI), a nonprofit foundation dedicated to educating patients and the public on the medicine development process.
Representing over 120,000 individuals with rare bleeding disorders, the Consortium brings deep patient insight and multi-stakeholder collaboration to the alliance.
This partnership reflects both organizations’ shared commitment to empowering patients and strengthening the role of informed, engaged communities in shaping the future of healthcare.
Learn about the latest major collaborations in the field of Rare Diseases with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia